HomeEPRSQ • OTCMKTS
add
Epirus Biopharmaceuticals Inc
Previous close
$0.00
Market cap
30.00 USD
Avg Volume
2.51K
P/E ratio
-
Dividend yield
-
Primary exchange
OTCMKTS
Market news
Financials
Income Statement
Revenue
Net income
(USD) | 2015info | Y/Y change |
---|---|---|
Revenue | 701.00K | 17,425.00% |
Operating expense | 47.18M | 48.92% |
Net income | -52.19M | -24.72% |
Net profit margin | -7.44K | 99.29% |
Earnings per share | -2.34 | 65.64% |
EBITDA | -46.00M | -45.99% |
Effective tax rate | 1.03% | — |
Balance Sheet
Total assets
Total liabilities
(USD) | 2015info | Y/Y change |
---|---|---|
Cash and short-term investments | 31.52M | 46.84% |
Total assets | 72.26M | 40.66% |
Total liabilities | 35.90M | 89.18% |
Total equity | 36.37M | — |
Shares outstanding | 26.18M | — |
Price to book | 0.00 | — |
Return on assets | -47.11% | — |
Return on capital | -64.10% | — |
Cash Flow
Net change in cash
(USD) | 2015info | Y/Y change |
---|---|---|
Net income | -52.19M | -24.72% |
Cash from operations | -46.58M | -31.33% |
Cash from investing | 841.00K | -93.16% |
Cash from financing | 55.82M | 30.29% |
Net change in cash | 10.05M | -48.88% |
Free cash flow | -13.64M | 24.57% |
About
Founded
2000
Headquarters
Website
Employees
73